The Abstract Submission Deadline is February 10, 2022 at midnight PST.
Abstracts accepted for the AChemS Annual Meeting are presented as posters.
ABSTRACT SUBMISSION NOTES:
Abstracts are limited to 1830 characters (including spaces, but not including title, authors and affiliations).
The Abstract Submission Fee is $75 for Student Members and $100 for all other submissions. Abstract fees are non-refundable.
Be sure to have your AChemS membership number (or the membership number of your sponsor) prior to starting the abstract submission process.
POSTER PRESENTERS: The poster display boards will accommodate posters up to 4' high x 8' wide in size (1.2 x 2.4m). Push pins and poster board numbers will be provided.
ORAL DATA BLITZ & POSTER PRESENTATION: Abstracts selected for oral data blitz presentations will be able to present a brief oral presentation in addition to their printed poster.
SYMPOSIA PRESENTERS: Symposia will follow a standard format. Each will begin with a short introduction (10 minutes) given by the symposium chair. Symposia will include four (4) invited speakers. Three will give talks of 25 minutes (plus 5 minutes for questions). A short talk of 15 minutes (plus 5 minutes for questions) is designated for graduate students, postdoctoral fellows or junior faculty.
ABSTRACT ELIGIBILITY RULES
Each abstract must be sponsored by a member of AChemS. A member of AChemS may sponsor only one abstract.
An individual may appear as first author on only one abstract and may present only one abstract at the
meeting; the first author does not have to be a member.
It is the responsibility of the presenting author and sponsor to ensure that all authors have given their consent to be listed on the submitted version of the abstract. If the presenting author/sponsor is found to be in violation of this rule, they may not be allowed to submit abstracts at future meetings.
The work reported in the abstract should be original research. Abstracts should generally not be submitted to the meeting if the work has been previously published.
To facilitate scientific communication, abstracts reporting studies with unidentified drugs, chemical compounds, or materials will not be accepted. All drugs, chemical compounds, and materials should be identified both in the abstract and during the meeting.